BioStock: DanCann Pharma’s CEO on the new acquisition
Danish biotech DanCann Pharma has acquired CannGros, the leading distributor of medical cannabis in Denmark. Through the acquisition, Dancann obtained licenses to import and distribute medical cannabis, as well as three approved products. The acquisition is paid for through a directed issue of units. BioStock reached out to DanCann’s CEO Jeppe Krog Rasmussen, for a comment on the long-term implications of the acquisition.
Read the full interview with Jeppe Krog Rasmussen at biostock.se:
https://www.biostock.se/en/2021/10/dancann-pharmas-ceo-on-the-new-acquisition/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/